
Ildiko ☕️
@ildikome
Interested in healthcare, law, patents, pharma, nutrition, microbiome, pediatric IBD & Celiac. Happy to have nuanced discussions.
ID: 33998514
21-04-2009 18:52:06
6,6K Tweet
1,1K Followers
1,1K Following

Today Arc Institute releases State, our first perturbation prediction AI model and an important step towards our goal of a virtual cell State is designed to learn how to shift cells between states (e.g. “diseased” to “healthy”) using drugs, cytokines, or genetic perturbations


Online now in GIE’s Articles in Press: "Endoscopy in inflammatory bowel disease: what every endoscopist should know" by Gursimran S. Kochhar and Partha Pal. giejournal.org/article/S0016-… #GITwitter Gursimran Kochhar MD @ParthaP32580643






⭐️I am thrilled to share our review in Gut Journal on #celiac disease and intestinal permeability! We think that the future of CeD prevention and treatment lies in barrier-targeted therapeutics! #MedTwitter #GITwitter #microbiome gut.bmj.com/content/early/…



Does Metformin affect outcomes in pts with IBD and type 2 DM? 💊🧐 ✅ Possibly! According to a population based study with >2500 pts and 3 years follow up showing: ⬇️ Use of steroids ⬇️ risk of ✂️ in CD Jessica C. Petrov, MD MSc Gursimran Kochhar MD Jami Kinnucan, MD, FACG, AGAF, FCCF Jana G Hashash, MD, MSc doi.org/10.1093/ibd/iz…


Happy to share our findings showing that high UPF is associated with an increased risk of relapse in patients with #CD. #IBD #Diet Prof. Nitsan Maharshak Shira zelber sagi Nutritional Therapy for IBD karger.com/doi/10.1159/00…


The microbiome is knocking on the clinicians' door Gianluca Ianiro, Siew Ng, Giovanni Cammarota, Harry Sokol, Eran Elinav ElinavLab WeersmaLab & colleagues update key microbiome findings ripe to bedside and challenges: loom.ly/gmJBDAE







